Cost-Effectiveness of the Clinical Management of Hepatocellular Carcinoma in Four Asian-Pacific Countries

Zehang Chen; Le‐Qun Li; Masatoshi Kudo; Hyeok Lee; Nicholas Graves; Pierce K. H. Chow; Asia-Pacific Hepatocellular Carcinoma Trials Group

doi:10.2139/ssrn.4834019

Related publications

Article2017

Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

Masao Omata, Ann‐Lii Cheng, Norihiro Kokudo, Masatoshi Kudo, Jeong Min Lee, Jidong Jia, Ryosuke Tateishi, Kwang–Hyub Han, Yoghesh K. Chawla, Shuichiro Shiina, Wasim Jafri, Diana A. Payawal, Takamasa Ohki, Sadahisa Ogasawara, Pei‐Jer Chen, Cosmas Rinaldi Adithya Lesmana, Laurentius A. Lesmana, Rino Alvani Gani, Shuntaro Obi, A. Kadir Dökmeci, Shiv Kumar Sarin

Article2017

Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan

Akihiro Nishie, Satoshi Goshima, Hiroki Haradome, Etsuro Hatano, Yasuharu Imai, Masatoshi Kudo, Masanori Matsuda, Utaroh Motosugi, Satoshi Saitoh, Kengo Yoshimitsu, Bruce Crawford, Eliza Kruger, Graeme Ball, Hiroshi Honda

Article2018

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle, Alejandro Forner, Josep M. Llovet, Vincenzo Mazzaferro, Fabio Piscaglia, Jean‐Luc Raoul, Peter Schirmacher, Valérie Vilgrain

Journal of Hepatology

Article2002

Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation

Josep M. Llovet

Gut

Article2018

PCN188 - ASSESSING THE ROBUSTNESS OF A COST-EFFECTIVENESS ANALYSIS OF LENVATINIB VERSUS SORAFENIB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA IN JAPAN

Shunya Ikeda, Masatoshi Kudo, Namiki Izumi, Satoshi Kaneko, Masahiro Kobayashi, Mie Azuma, Ronda Copher, Suchin Virabhak, David Mitchell, Genevieve Meier, Mika Ishii